Literature DB >> 16550923

Schwartz-Jampel syndrome and perlecan deficiency.

M Stum1, C S Davoine, B Fontaine, S Nicole.   

Abstract

Schwartz-Jampel syndrome (SJS) is a rare autosomal recessive disorder characterized by the association of myotonia with chondrodysplasia. A positional cloning strategy allowed the localization and the identification of perlecan as the disease causing gene. Another human recessive disorder, the Dyssegmental Dysplasia, Silverman-Handmaker type (DDSH), is caused by functional null mutations of the perlecan gene. A gene-dosage effect seems to account for the correlation between the phenotype and the mutations within the gene: SJS would be associated with hypomorph mutations of the perlecan gene and DDSH would be due to the absence of functional perlecan. Perlecan is the major heparan sulfate proteoglycan of extracellular matrix and basement membranes that displays various functions. Based on these functions, several hypotheses are evoked to explain chondrodysplasia and the unusual myotonia in SJS. Mouse models are invaluable tools to explore these hypotheses. Since knock-out mice develop a phenotype similar to DDSH, we have developed a SJS mouse model by reproducing the hypomorph effect of SJS perlecan mutation in this species. The characterization of this mouse model will help to understand the pathophysiological mechanism leading to this multisystemic human disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16550923

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  6 in total

1.  Perlecan-containing pericellular matrix regulates solute transport and mechanosensing within the osteocyte lacunar-canalicular system.

Authors:  Bin Wang; Xiaohan Lai; Christopher Price; William R Thompson; Wen Li; Tonima R Quabili; Wei-Ju Tseng; Xiaowei Sherry Liu; Hong Zhang; Jun Pan; Catherine B Kirn-Safran; Mary C Farach-Carson; Liyun Wang
Journal:  J Bone Miner Res       Date:  2014-04       Impact factor: 6.741

2.  Perlecan domain V is neuroprotective and proangiogenic following ischemic stroke in rodents.

Authors:  Boyeon Lee; Douglas Clarke; Abraham Al Ahmad; Michael Kahle; Christi Parham; Lisa Auckland; Courtney Shaw; Mehmet Fidanboylu; Anthony Wayne Orr; Omolara Ogunshola; Andrzej Fertala; Sarah A Thomas; Gregory J Bix
Journal:  J Clin Invest       Date:  2011-07-11       Impact factor: 14.808

Review 3.  Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.

Authors:  Mary C Farach-Carson; Curtis R Warren; Daniel A Harrington; Daniel D Carson
Journal:  Matrix Biol       Date:  2013-08-31       Impact factor: 11.583

Review 4.  Heart valve development: regulatory networks in development and disease.

Authors:  Michelle D Combs; Katherine E Yutzey
Journal:  Circ Res       Date:  2009-08-28       Impact factor: 17.367

5.  Analysis of Association between Morphometric Parameters of Growth Plate and Bone Growth of Tibia in Mice and Humans.

Authors:  Kimberly Wilson; Yu Usami; Danielle Hogarth; Amanda L Scheiber; Hongying Tian; Takeshi Oichi; Yulong Wei; Ling Qin; Satoru Otsuru; Satoru Toyosawa; Masahiro Iwamoto; Joshua M Abzug; Motomi Enomoto-Iwamoto
Journal:  Cartilage       Date:  2020-01-30       Impact factor: 3.117

6.  Immune myopathies with perimysial pathology: Clinical and laboratory features.

Authors:  Robert C Bucelli; Alan Pestronk
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2018-01-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.